ArticleFundamental research2026
Fine-tuning of the CRWN2-NTL9 module to repress PR1 expression by a viral effector during geminivirus infection.
Article in Fundamental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
CROWDED NUCLEIs (CRWNs) are nuclear lamina proteins that play an important role in plant immunity. Nevertheless, the molecular mechanism of how CRWNs regulate host immunity and the mechanism by which pathogens manipulate CRWN-mediated immunity regulation is not understood. In this study, we report that CRWN2 negatively regulates anti-geminiviral defense responses through enhancing the function of NAC with transmembrane motif 1-like 9 (NTL9), and the CRWN2-NTL9 module attenuating host defenses is exploited by the geminivirus tomato yellow leaf curl China virus (TYLCCNV). CRWN2 directly interacts with the transcription factor NTL9 and enhances its binding activity on the promoter of the pathogenesis-related gene
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.